SEALSQ (NASDAQ:LAES) Stock

SEALSQ

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

SEALSQ Corp

WIIM

KRUS

Kura Sushi USA shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance.

Republic Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>) has outperformed the market over the past 15 years by 8.71% on an annualized basis producing an average annual return of 20.96%. Currently, Republic Services has a market capitalization of $74.78 billion. 
Buying $1000 In RSG: If an investor had bought $1000 of RSG stock 15 years ago, it would be worth $17,179.47 today based on a price of $239.31 for RSG at the time of writing.
<h3>Republic Services's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752005714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $1000 Invested In Republic Services 15 Years Ago Would Be Worth Today

AEHR

Aehr Test Systems shares are trading lower after the company reported worse-than-expected Q4 sales results.

ELPW

Elong Power Holding Entered Into Strategic Cooperation Agreement With Consumer Protection Agency of the Republic of Indonesia To Address Electricity Access Issues

Tyra Biosciences, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYRA#NASDAQ">TYRA</a>), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that a late-breaking abstract has been accepted for presentation at The Endocrine Society's Annual Meeting (ENDO 2025), taking place July 12-15, 2025 in San Francisco, CA.
Details of the poster presentation are below:
<ul>
<li>Title: "TYRA-300 Promotes Bone Growth In Two Mouse Models Of FGFR3-related Skeletal Dysplasia"</li>
<li>Abstract: SUN-730</li>
<li>Presenting Author: Jacqueline H. Starrett, Ph.D., Tyra Biosciences</li>
<li>Date/Time: July 13, 2025, 12:00 PM - 1:30 PM, ENDOExpo: Poster Area</li>
<li>Session: Session P70 - BONE AND MINERAL METABOLISM: Rare Bone and Genetic Disorders</li>
</ul>

TYRA

Tyra Biosciences Says Late-Breaking Abstract On TYRA-300 Preclinical Results Accepted For Presentation At ENDO 2025

Lake Shore Bancorp, Inc. ("Lake Shore Federal Bancorp") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSBK#NASDAQ">LSBK</a>), the holding company for Lake Shore Savings Bank (the "Bank"), announced today that all regulatory approvals have been received to close the conversion of Lake Shore, MHC from mutual to stock form and the related stock offering by Lake Shore Bancorp, Inc. ("Lake Shore Bancorp"), the proposed new stock holding company for Lake Shore Bank and the Bank's conversion from a federal savings bank to a New York chartered commercial bank.
Closing is expected to occur after the close of business on July 18, 2025. Lake Shore Bancorp's common stock is expected to begin trading on the Nasdaq Global Market under the trading symbol "LSBK" on July 21, 2025.
As a result of the subscription offering, Lake Shore Bancorp expects to sell a total of 4,950,460 shares of its common stock (approximately the midpoint of the offering range) at a price of $10.00 per share for total gross proceeds of $49.5 million. All valid stock orders submitted by eligible account holders, supplemental eligible account holders and voting members in the subscription offering will be filled in full. Lake Shore Bancorp's transfer agent, Computershare Trust Company, N.A. ("Computershare"), expects to mail Direct Registration System ("DRS") Book-Entry statements for shares purchased in the subscription offering and interest checks, on or about July 21, 2025.

Offerings

LSBK

Lake Shore Bancorp Receives Regulatory Approvals For MHC Conversion And $49.5M Stock Offering Of ~4.95M Shares At $10/Share; Trading To Begin July 21, 2025

RXST

RxSight shares are trading lower after the company cut its 2025 revenue guidance from $160M–$175M to $120M–$130M.

Biotech

Events

General

VCYT

Veracyte To Present Multiple Afirma GRID Studies At ENDO 2025

Guidance

RxSight Sees Prelim. Q2 Revenue $33.6M, Down 4% YoY; Co. Also Cuts 2025 Revenue Guidance From $160M-$175M To $120M-$130M

Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) raises FY2025 sales outlook from $275.000 million-$279.000 million to $281.000 million vs $278.703 million estimate.

Kura Sushi USA Raises FY2025 Sales Guidance from $275.000M-$279.000M to $281.000M vs $278.703M Est

- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies -
- SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA -
- Solid expects to initiate Phase 1b clinical trial of SGT-501 in the fourth quarter of 2025 -
- Expands Solid's clinical pipeline to include first cardiac indication with urgent unmet medical need -

SLDB

Solid Biosciences Receives FDA IND And Health Canada CTA Approval For First-In-Class Cardiac Gene Therapy To Treat Catecholaminergic Polymorphic Ventricular Tachycardia

Earnings

Earnings Beats

Earnings Misses

Penguin Solutions, Inc. - Ordinary Shares

PENG

Penguin Solutions Q3 Adj. EPS $0.47 Beats $0.33 Estimate, Sales $324.25M Miss $328.81M Estimate

Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 655.56 percent. The company reported quarterly sales of $73.965 million which beat the analyst consensus estimate of $71.832 million by 2.97 percent. This is a 17.25 percent increase over sales of $63.082 million the same period last year.

Kura Sushi USA Q3 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $73.965M Beat $71.832M Estimate

The Department of Energy (DOE) under President Donald Trump released a report warning that the planned shutdown of existing power plants, combined with delays in bringing new energy sources online, could result in a significant increase in blackouts by the <a href="https://www.benzinga.com/trading-ideas/small-cap-analysis/25/07/46299343/oklo-nuscale-hims-defy-trump-tariffs-and-power-the-russell-2000-toward-new-highs">end of the decade.</a>
<h3 class="wp-block-heading">Key Findings from the DOE Report:</h3>
The DOE's report found that approximately 104 gigawatts (GW) of current power generation capacity are set to be retired by 2030.&nbsp;
If these facilities are not replaced promptly, the number of hours Americans experience power outages each year could jump from the current single digits to more than 800 hours without power each year.
Read Next: <a href="https://www.benzinga.com/markets/tech/25/07/46298744/solar-stocks-sink-trump-slashes-green-tax-breaks?utm_source=articleShare">Solar Stocks Sink: Trump Slashes Green Tax Breaks</a>&nbsp;
While 209 GW of new capacity is scheduled to come online by 2030, only 22 GW of that will be from reliable, always-available (baseload) sources. The report also notes that even if no retirements occurred, the risk of outages in some regions could still triple.
Secretary of Energy Chris Wright <a href="https://www.foxbusiness.com/economy/trumps-energy-department-warns-americans-could-face-800-hours-blackouts-2030">told</a> Fox Business that the administration is focused on increasing energy supply from all affordable, reliable and secure sources to meet rising demand and support the country's competitiveness in AI and manufacturing.
&#8220;In the coming years, America's reindustrialization and the AI race will require a significantly larger supply of around-the-clock, reliable, and uninterrupted power,&#8221; Wright said.&nbsp;
&#8220;President Trump's administration is committed to advancing a strategy of energy addition, and supporting all forms of energy that are affordable, reliable, and secure,&#8221; he added. &#8220;If we are going to keep the lights on, win the AI race, and keep electricity prices from skyrocketing, the United States must unleash American energy.&#8221;
<h3 class="wp-block-heading">Nuclear Alternative:&nbsp;</h3>
Nuclear plants provide continuous, stable electricity, regardless of weather or time of day, unlike solar and wind energy. Nuclear energy could help to mitigate potential energy shortages and is viewed favorably by the Trump administration.
In fact, President Trump signed a <a href="https://www.benzinga.com/news/mid-cap/25/05/45587750/uranium-stocks-surge-trumps-nuclear-push-sparks-double-digit-gains">series of executive orders</a> at the end of May aimed at revitalizing the nuclear energy sector.&nbsp;
Trump invoked the Defense Production Act to declare a national emergency regarding the U.S. reliance on foreign uranium supplies and directed federal agencies to accelerate nuclear project development and remove regulatory barriers. 
As federal support shifts toward nuclear technologies, investors may want to monitor the sector.&nbsp;
Some companies that could benefit include Oklo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), NuScale Power Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>), Nano Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) and Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>).&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46284237/sofi-ready-to-capture-the-opportunity-as-trumps-big-beautiful-plan-restricts-federal-student-loans?utm_source=articleShare">SoFi Ready To &#8216;Capture The Opportunity&#8217; As Trump&#8217;s &#8216;Big, Beautiful&#8217; Plan Restricts Federal Student Loans</a></li>
</ul>
Photo: Shutterstock

Mid Cap

Politics

Movers

Tech

OKLO

Get Ready For 800 Hours Of Blackouts, Trump's DOE Warns

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.93 by 28.8 percent. This is a 37.14 percent decrease over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $32.32 million which beat the analyst consensus estimate of $32.29 million by 0.08 percent. This is a 16.44 percent decrease over sales of $38.68 million the same period last year.

Saratoga Investment Q1 Adj. EPS $0.66 Misses $0.93 Estimate, Sales $32.32M Beat $32.29M Estimate

Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 101.19 percent decrease over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $14.089 million which missed the analyst consensus estimate of $14.823 million by 4.95 percent. This is a 15.13 percent decrease over sales of $16.600 million the same period last year.

Aehr Test Systems Q4 Adj. EPS $(0.01), Inline, Sales $14.089M Miss $14.823M Estimate

POAI

On July 1, Predictive Oncology Entered Equity Purchase Agreement With Ya Ii Pn, Ltd.

MBLY

Mobileye Global shares are trading lower after the company announced a 45 million secondary share offering.

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the Company will hold a conference call and webcast on Wednesday, July 9, 2025 at 8:00 a.m. ET to disclose topline results from the randomized, placebo-controlled portion of the Phase 2 trial evaluating bivamelagon, an investigational oral melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity.
Conference Call Information Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, July 9, to discuss these clinical data. Participants may register for the conference call <a href="https://www.globenewswire.com/Tracker?data=PMUHCc_o63ptWycjH6Y7DV9X1bk72WjNQ44dm-8QhwgmGSA24YcTeajqP55OvzeSK494H_JZoC6YnW8aeYNWUDYqpqpV7oQRrF_fQO8RSqY=">here</a>. A webcast of the call will also be available under "Events and Presentations" in the Investor Relations section of the Rhythm Pharmaceuticals website at <a href="https://ir.rhythmtx.com/">https://ir.rhythmtx.com/</a>. The archived webcast will be available on Rhythm Pharmaceuticals' website approximately two hours after the conference call and will be available for at least 30 days following the call.
About the Bivamelagon Phase 2 Trial The Phase 2 trial is a randomized, placebo-controlled, double-blind study to assess the effect of bivamelagon (LB54640) on safety, weight reduction, hunger, and quality of life in patients 12 years of age and older (N=28) with hypothalamic obesity. During the placebo-controlled, randomized portion of the trial, patients took an oral daily dose of either bivamelagon, low (200 mg), middle (400 mg), or high dose (600 mg), or placebo for 14 weeks. The primary endpoint of the study was the change from baseline in body mass index after 14 weeks of treatment, and patients may continue on therapy in the open label extension portion for up to 52 weeks.

RYTM

Rhythm Pharmaceuticals To Reveal Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity

SR Bancorp, Inc. (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRBK#NASDAQ">SRBK</a>), the holding company for Somerset Regal Bank, announced today that the Company has authorized a stock repurchase program for up to 10% of the Company's outstanding shares of common stock (886,137 shares). This is the Company's second stock repurchase program since completing its mutual-to-stock conversion and related stock offering on September 19, 2023.

Buybacks

SRBK

SR Bancorp Announces Company Has Authorized A Stock Repurchase Program For Up To 10%, 886,137 Shares, Of The Company's Outstanding Shares Of Common Stock

Press Releases

WISeSat Signs a Service Agreement with Astrocast to Allow Access to Astrocast's Operational Satellite Constellation

SEALSQ Strengthens IoMT Security and Edge AI Integration with Post-Quantum Technology to Safeguard Next-Generation Healthcare Systems

WISeSat.Space on Track to Deploy 100-Satellite Constellation by 2027 in Cooperation with WISekey and SEALSQ

SEALSQ Finalizes Strategic Investment in WeCan Group with 28.30% Equity Stake Acquisition

WISeKey Shareholders Approved All Agenda Items of the 2025 Annual General Meeting

SEALSQ and WISeKey Launch the Quantum Corridor: A New Era of Cross-Border DeepTech Innovation

SEALSQ Quantum-Resistant Technology Tackles Potential Bitcoin's Quantum Vulnerabilities

SEALSQ Corp Announces H1 2025 Preliminary Revenue and Other Key Financial Metrics: Updates on Planned Deployment of Post-Quantum Security Solutions by 2025 Year-End

SEALSQ Increased Its Quantum Investment Fund to Over $35 Million and Provides Update on Strategic Quantum Technology Convergence

SEALSQ Commences Global Deployment of its GSMA-Accredited eUICC with Telcos, Integrating A Pioneering Post-Quantum Ready Cryptographic Security Technology

LAES

WKEY

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega

Blaize Holdings

CEVA

Canadian Solar

GSI Technology

Himax Technologies, Inc. - American depositary shares, each of which represents two ordinary shares.

Himax Techs

Intchains Group Limited - American Depositary Shares

Intchains Gr

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

JinkoSolar Holding Co

Kopin

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

MaxLinear

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Penguin Solutions

QuickLogic

Silicon Motion Technology Corporation - American Depositary Shares, each representing four ordinary shares

Comments

SEALSQ

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL